HLA allele selection for designing peptide vaccines

Genetic Analysis - Biomolecular Engineering

Volumn 13, Issue 3, 1996, Pages 81-86

  Gulukota, Kamalakar ^a   DeLisi, Charles ^a  

^a Boston University   (United States)

Author keywords

Antigenic variation; Herd immunity; Linkage disequilibrium; Major histocompatibility complex; NP complete

Indexed keywords

HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; ARTICLE; ETHNIC GROUP; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFLUENZA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030250386     PISSN: 10503862     EISSN: None     Source Type: Journal    
DOI: 10.1016/1050-3862(95)00156-5     Document Type: Article

References (16)

1. [1] Brower RC, England R, Takeshita T, Kozlowski S, Margulies DH, Berzofsky JA, DeLisi C. Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol 31 (16); 1994: 1285-1293.
2. [2] Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJM, Oseroff C, Yuan L, Ruppert J, Sidney J, Guercio MFD, Southwood S, Kubo RT, Chestnut RW, Grey HM, Chisari FV. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153; 1994: 5586-5592.
3. [3] Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koppe B, Sigmund K, Bangham CRM, McMichael AJ. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (London) 375; 1995: 606-611.
4. [4] Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide - MHC complexes: A comparison of the conformations of five viral peptides presented by HLA - A2. Cell 75; 1993: 693-708.
5. [5] Rammensee HG, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 41; 1995: 178-228.
6. [6] Vajda S, Weng Z, Rosenfeld R, DeLisi C. Sandor Vajda, Zhiping Weng, Rakefet Rosenfeld, and Charles DeLisi. Effect of conformational flexibility and solvation on receptor - ligand binding free energies. Biochemistry 33; 1994: 13977-13988.
7. [7] Janeway CA, Travers P. ImmunoBiology. Garland Publishing, Inc., New York, 1994.
8. [8] The WHO Nomenclature Committee for factors of the HLA system. Nomenclature for factors of the HLA system. Immunogenetics 36; 1992: 135-148.
9. [9] Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference, chapter Vol. 1, Ch. W15.1, Oxford University Press, Tokyo, 1992; 1065-1091.
10. [10] Cormen TH, Leiserson CE, Rivest RL. Introduction to Algorithms. McGraw-Hill, New York, 1990.
11. [11] Meister GE, Roberts CGP, Berzofsky JA, DeGroot AS. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from mycobacterium tuberculosis and HIV protein sequences. Vaccine 13; 1995: 581-591.
12. [12] Takeshita T, Takahashi H, Kozlowski S, Ahlers JD, Pendleton CD, Moore RL, Nakagawa Y, Yokomura K, Fox BS, Margulies DH, Berzofsky JA. Molecular analysis of the same HIV peptide functionally binding to both a class I and class II MHC molecule. J Immunol 154; 1995: 1973-1986.
13. [13] Fine PEM. Herd immunity: History, theory, practice. Epidemiol Rev 15(2); 1993: 265-301.
14. [14] Salk FE, Drucker J. Non infectious polio virus vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines, W.B. Saunders, Philadelphia, 1988; 158-181.
15. [15] Levine MM. Modern vaccines: Enteric infections. Lancet 335; 1990: 958-961.
16. [16] Fine PEM, Rodrigues LC. Modern vaccines: Mycobacterial diseases. Lancet 335; 1990: 1016-1020.